COVID-19 and Renin Angiotensin Blockers: Current Evidence and Recommendations.

Messerli, Franz H; Siontis, George C M; Rexhaj, Emrush

Messerli, Franz H; Siontis, George C M; Rexhaj, Emrush.

Messerli FH; Department of Cardiology, Bern University Hospital, University of Bern, Switzerland (F.H.M., G.C.M.S., E.R.).
Siontis GCM; Jagiellonian University, Krakow, Poland (F.H.M.).
Rexhaj E; Division of Cardiology, Mount Sinai Health Medical Center, Icahn School of Medicine, New York (F.H.M.).

Circulation ; 141(25): 2042-2044, 2020 06 23.

Article in English | MEDLINE | ID: covidwho-52619

Subject(s)

Coronavirus Infections/pathology; Pneumonia, Viral/pathology; Renin-Angiotensin System; Angiotensin Receptor Antagonists/pharmacology; Angiotensin Receptor Antagonists/therapeutic use; Animals; Betacoronavirus/isolation & purification; COVID-19; Coronavirus Infections/virology; Disease Models, Animal; Guidelines as Topic; Humans; Hypertension/drug therapy; Losartan/pharmacology; Losartan/therapeutic use; Odds Ratio; Pandemics; Pneumonia, Viral/virology; Renin-Angiotensin System/drug effects; SARS-CoV-2

Keywords

COVID-19; angiotensin-converting enzyme inhibitors; pneumonia, viral

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Renin-Angiotensin System / Coronavirus Infections Type of study: Prognostic study / Randomized controlled trials Limits: Animals / Humans Language: English Journal: Circulation Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google